Michael A Daniele
Overview
Explore the profile of Michael A Daniele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aroche A, Nissan H, Daniele M
Adv Healthc Mater
. 2024 Nov;
14(1):e2401782.
PMID: 39558769
Hydrogel-forming microneedles are constructed from or coated with polymeric, hydrophilic materials that swell upon insertion into the skin. Designed to dissolve or disintegrate postinsertion, these microneedles can deliver drugs, vaccines,...
2.
Wu Y, Barbieri E, Kilgore R, Moore B, Chu W, Mollica G, et al.
J Chromatogr A
. 2024 Sep;
1736:465396.
PMID: 39342729
Adenovirus (AdVs) is the viral vector of choice in vaccines and oncolytic applications owing to its high transduction activity and inherent immunogenicity. For decades, AdV isolation has relied on ultracentrifugation...
3.
Shastry S, Barbieri E, Minzoni A, Chu W, Johnson S, Stoops M, et al.
J Chromatogr A
. 2024 Sep;
1734:465320.
PMID: 39217737
Adeno-associated viruses (AAVs) have emerged as a prominent family of vectors for gene delivery, providing therapeutic options to diseases once deemed incurable. At the same time, they necessitate efficient and...
4.
Kilgore R, Moore B, Sripada S, Chu W, Shastry S, Barbieri E, et al.
Biotechnol Bioeng
. 2024 Aug;
121(11):3484-3501.
PMID: 39099106
Exosomes are gaining prominence as vectors for drug delivery, vaccination, and regenerative medicine. Owing to their surface biochemistry, which reflects the parent cell membrane, these nanoscale biologics feature low immunogenicity,...
5.
Sripada S, Hosseini M, Ramesh S, Wang J, Ritola K, Menegatti S, et al.
Biotechnol Adv
. 2024 Jun;
74:108391.
PMID: 38848795
Viral vectors are an emerging, exciting class of biologics whose application in vaccines, oncology, and gene therapy has grown exponentially in recent years. Following first regulatory approval, this class of...
6.
Reynolds J, Wilkins M, Martin D, Taggart M, Rivera K, Tunc-Ozdemir M, et al.
Sensors (Basel)
. 2024 Apr;
24(7).
PMID: 38610546
The study of plant electrophysiology offers promising techniques to track plant health and stress in vivo for both agricultural and environmental monitoring applications. Use of superficial electrodes on the plant...
7.
Barbieri E, Mollica G, Moore B, Sripada S, Shastry S, Kilgore R, et al.
Biotechnol Bioeng
. 2023 Nov;
121(2):618-639.
PMID: 37947118
The recent uptick in the approval of ex vivo cell therapies highlights the relevance of lentivirus (LV) as an enabling viral vector of modern medicine. As labile biologics, however, LVs...
8.
Shastry S, Chu W, Barbieri E, Greback-Clarke P, Smith W, Cummings C, et al.
Biotechnol J
. 2023 Sep;
19(1):e2300230.
PMID: 37728197
Adeno-associated viruses (AAVs) have acquired a central role in modern medicine as delivery agents for gene therapies targeting rare diseases. While new AAVs with improved tissue targeting, potency, and safety...
9.
Prodromou R, Moore B, Chu W, Deal H, San Miguel A, Brown A, et al.
Adv Funct Mater
. 2023 Aug;
33(14).
PMID: 37576949
The use of benign stimuli to control the binding and release of labile biologics for their isolation from complex feedstocks is a key goal of modern biopharmaceutical technology. This study...
10.
Rivera K, Bliton R, Burclaff J, Czerwinski M, Liu J, Trueblood J, et al.
Cell Mol Gastroenterol Hepatol
. 2023 Aug;
16(5):823-846.
PMID: 37562653
Background And Aims: Hypoxia in the intestinal epithelium can be caused by acute ischemic events or chronic inflammation in which immune cell infiltration produces inflammatory hypoxia starving the mucosa of...